
Strides Pharma Science Limited has informed the Exchange about press release dated 21-Mar-2022 titled Strides partners with Medicines Patent Pool (MPP) to commercialize the generic version of Pfizer���s COVID-19 Oral Treatment across 95 markets
Filed with NSE ·

Strides Pharma Science Limited has informed the Exchange about press release dated 21-Mar-2022 titled Strides partners with Medicines Patent Pool (MPP) to commercialize the generic version of Pfizer���s COVID-19 Oral Treatment across 95 markets
6ix hasn’t read this filing yet.
Strides Pharma Science Ltd on 6ix
Follow Strides Pharma Science into a list and get an email when it puts out news.
Follow Strides Pharma Science